KCR Expands Its Presence in the U.S. Market

KCR Expands Its Presence in the U.S. Market


The move is another milestone in the company strategy to be closer to partners and clients at the heart of the East Coast biotech and pharma hub. "We are very excited about the new location in Boston and the ability to serve our U.S. clients on the same ground," said Mike Jagielski, CEO & President of KCR.



from Biotech News